Halaman, Ric Andrei .

HRN: 25-13-57  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2025
CEFUROXIME 750MG (VIAL)
05/30/2025
06/06/2025
IV
260mg
Q8
BFC; URTI
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  URTIBloodstreamProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: